Sports Medicine and Athlete Performance Using PRP Therapy

Learn how prp therapy in sports medicine promotes healing and helps athletes return to peak performance faster.

Abstract

As a practitioner dedicated to integrative, evidence-based care, I am constantly exploring advanced therapeutic options to improve patient outcomes. This post delves into the powerful synergy between Platelet-Rich Plasma (PRP) and Protein Concentrate (PC), an emerging strategy redefining our approach to musculoskeletal and joint health. We will explore the scientific underpinnings of this combination therapy, understanding how PC, particularly its high concentration of Alpha-2-Macroglobulin (A2M) and other beneficial proteins, acts as a potent anti-inflammatory and anti-catabolic agent. I will detail the clinical rationale for using this dual therapy, its economic advantages for a cash-pay practice, and specific treatment protocols for conditions like knee osteoarthritis, chronic tendinopathies, and adhesive capsulitis. By combining this advanced biological therapy with foundational chiropractic care and rehabilitation, we provide patients with a comprehensive, multifaceted approach to better, longer-lasting results.

Understanding Protein Concentrate: More Than Just PRP

In the world of regenerative medicine, many of us are familiar with Platelet-Rich Plasma, or PRP. It’s a cornerstone of what we do. But what if we could take the healing potential of a patient’s own blood a step further? This is where Protein Concentrate (PC) comes in.

To understand PC, let’s start with a basic blood draw. When we process blood to create PRP, we also obtain another component: Platelet-Poor Plasma (PPP). Historically, this has often been discarded. However, we now know that this PPP is a reservoir of valuable proteins. By running the PPP through a specialized filtration system, we can isolate and concentrate these proteins, creating what we call Protein Concentrate.

The Power Players Within Protein Concentrate

So, why is this concentrated fluid so important? It’s all about what’s inside. PC is rich in several key biomolecules that play a critical role in modulating the joint environment.

• Alpha-2-Macroglobulin (A2M): This is the star player. A2M is a very large protein molecule (around 720 kilodaltons) that acts as a powerful “master inhibitor” of proteases—the enzymes that break down cartilage and other tissues. When I inject PC into a joint, the A2M molecules essentially trap and neutralize these destructive enzymes, halting the degenerative, catabolic cascade that drives conditions like osteoarthritis.
• Interleukin-1 Receptor Antagonist (IL-1Ra): Interleukin-1 (IL-1) is a primary inflammatory cytokine. It signals pain, triggers swelling, and promotes tissue degradation. PC contains IL-1Ra, a naturally occurring protein that blocks the IL-1 receptor. By preventing IL-1 from binding to its receptor, we can significantly reduce joint pain and inflammation, providing rapid symptom relief for our patients.
• Growth Factors: While PRP is known for its growth factors, PC also contains its own beneficial array, including:

• • Vascular Endothelial Growth Factor (VEGF): Promotes the formation of new blood vessels, improving circulation and nutrient delivery to the healing tissue.
  • Epidermal Growth Factor (EGF): Stimulates our own adult mesenchymal stem cells, the body’s natural repair crews.
  • Platelet-Derived Growth Factor (PDGF-BB): Another potent stimulator of mesenchymal stem cells, encouraging tissue regeneration.

By adding Protein Concentrate to our treatments, we are not just stimulating repair with PRP; we are also actively protecting the joint from further breakdown and calming the inflammatory fire that causes pain.

Enhancing Clinical Practice with PRP Plus Protein Concentrate

In my practice, which combines functional medicine, advanced chiropractic care, and regenerative therapies, the goal is always to provide the most effective and comprehensive care possible. Integrating PC with PRP is a game-changer, setting a new standard.

A Differentiator in a Crowded Market

Many clinics now offer PRP injections. To truly stand out and provide superior value, we must offer something more. The combination of PRP + PC is a significant practice differentiator. It allows me to explain to my patients that we are not just providing a “good” option (PRP alone) but a “best” option that tackles their condition from two critical angles: anabolic (building up) with PRP’s growth factors and anti-catabolic (preventing breakdown) with PC’s powerful inhibitors.

This dual approach is not just a marketing tool; it’s a clinically superior strategy. When you inject A2M into a joint, its large size prevents it from migrating out easily. It remains in the joint space, where it irreversibly binds to and neutralizes harmful proteases, effectively “locking them down” and stopping their destructive activity. This provides powerful symptom relief and creates a healthier environment for the PRP to work its magic. This is particularly valuable for in-season athletes who need to feel better and perform quickly without resorting to cortisone injections, which we know can have detrimental long-term effects on cartilage health.

The Economic and Value-Based Case

For those of us operating in a cash-pay model, we must provide services that patients recognize as valuable and worth the investment.

• Good, Better, Best Model: We can structure our offerings to give patients a choice. PRP alone can be our “good” or standard option. But for those seeking faster, more durable, and more comprehensive results, the “best” option is PRP + PC. This premium service is worth a higher price because it is built on a superior mechanism of action.
• Justifying Premium Pricing: When a patient is paying out of pocket, they want the best possible chance of success. By combining our biological injection with a full system of care—including advanced rehabilitation, laser therapy, or shockwave therapy—we stack the deck in the patient’s favor. I can confidently tell my patients, “We are creating a comprehensive system to optimize your outcome.” Patients are willing to pay for better outcomes and the confidence that they are receiving the most advanced care available.
• Incremental Margin: From a business perspective, the added cost of preparing PC is relatively small compared to the significant value and incremental revenue it adds. For example, if a standard PRP injection is priced at $1,500 with a cost of goods around $250, adding PC might allow for a total price of 125, making the incremental profit margin substantial.

The Evidence Supporting Long-Term Durability

The theoretical benefits are clear, but what does the research show? While the field is still evolving, early evidence is incredibly promising.

One compelling paper by Dr. Mihai-Catalin Schineanu, published in the Journal of Medicine and Life in 2016, followed 82 knees with Grade 2, 3, and even 4 osteoarthritis that were treated with what he termed a “colloid protein fluid concentrate” (essentially a form of PC). The results were remarkable. Patients showed significant statistical improvements at three months, with the results sustained for up to three years. This is a profound finding. We know from other studies that the benefits of PRP alone for knee osteoarthritis typically last about 12 to 18 months. The addition of the anti-catabolic protein concentrate appears to dramatically extend the durability of the treatment effect. Even patients with Grade 4 “bone-on-bone” osteoarthritis saw benefits, which is truly encouraging.

Of course, science requires a balanced view. Not every study has found this to be a “secret sauce,” and some randomized controlled trials have shown conflicting outcomes. However, as a clinician, it is my responsibility to present a balanced perspective. I explain to my patients that while this is a highly promising therapy with strong supporting evidence and a clear mechanism of action, it’s not a guaranteed cure-all. This transparency builds trust and clinical integrity. When you explain why a therapy might work for them and acknowledge its limitations based on scientific evidence, you empower the patient and enhance your credibility.

Sports Injury Rehabilitation- Video

Clinical Application and Patient Selection: My Protocols

Crafting an effective treatment plan requires careful patient selection and a refined protocol. Here is how I approach it in my clinic.

Knee Osteoarthritis (Grade 2-3)

This is a primary indication. For patients with moderate osteoarthritis, especially those with an effusion (joint swelling), the first step is crucial.

1. Aspirate the Effusion: Before injecting anything, I always aspirate the knee to remove as much of the inflammatory “sludge”—the synovial fluid filled with destructive enzymes and inflammatory cytokines—as possible. This clears the battlefield.
2. Inject PRP + PC: I then inject the combination of PRP and PC. For knees, which are large-volume joints, I typically use a 1:1 volume ratio. A total injection volume of 10 cc is very reasonable for a knee and should not cause undue pressure or discomfort.

Chronic Tendinopathies (e.g., Tennis Elbow, Achilles Tendinopathy)

For damaged tendons, the strategy is slightly different.

1. Intra-tendinous PRP: I inject the PRP directly into the degenerated, dysfunctional part of the tendon (the “intra-tendinous” space) to stimulate a healing response.
2. Peri-tendinous PC: I then bathe the area surrounding the tendon (the “peri-tendinous” space) with the Protein Concentrate. This helps quell local inflammation and inhibit enzymes that contribute to tendon breakdown, providing both pain relief and a protective effect.

Adhesive Capsulitis (Frozen Shoulder)

Frozen shoulder is a condition I see frequently in my practice, and it responds exceptionally well to this integrated approach.

1. Hydrodilation: First, I perform a hydrodilation procedure in which I gently inject a large volume of saline into the joint capsule. This mechanically stretches the tight, fibrotic capsule from the inside out, immediately improving range of motion.
2. Inject PC: Following the hydrodilation, I inject the Protein Concentrate directly into the joint space. A2M and IL-1Ra act immediately, blocking the inflammatory and catabolic processes that drive capsular fibrosis and pain.
3. Integrative Chiropractic and Rehabilitation: This biological intervention is not a standalone cure. It is a powerful facilitator. The patient must follow up with a dedicated protocol of chiropractic adjustments to restore proper glenohumeral and cervicothoracic mechanics, along with physical therapy to maintain the newfound range of motion. The injection makes the rehabilitation process far more tolerable and effective.

The Critical Role of Data Collection

How do I know my protocols are effective? Because I track my data. Without data, you are just guessing. I cannot overstate the importance of collecting outcome data on every single regenerative procedure patient. Whether it’s on a simple spreadsheet or through a sophisticated registry service, this data is invaluable.

In my own patient cohorts, I have consistently observed that the PRP + PC group shows a more rapid and robust improvement in pain and function scores than the PRP-only group. For example, patients receiving the combination therapy often report feeling significantly better within the first two to three weeks, whereas the PRP-only group’s improvement curve is typically slower. This data allows me to:

• Set realistic expectations for new patients.
• Refine and improve my treatment protocols over time.
• Demonstrate value during patient consultations by showing them real-world results from my own clinic.

Final Considerations: The Importance of Informed Consent

As responsible clinicians, we must also educate our patients on the regulatory landscape. The vast majority of applications of PRP and PC in clinical settings are considered off-label. It is our duty to clearly explain what this means—namely, that while the procedure is legal and supported by a growing body of scientific evidence, it is not being used for the specific indication approved by regulatory bodies such as the FDA. This conversation, grounded in the supporting scientific literature, is a cornerstone of ethical practice and informed consent.

Conclusion: A Synergistic and Structured Approach

In conclusion, the practice of regenerative medicine is evolving beyond simple, commodity-like injections. We combine PRP’s anabolic, regenerative power with Protein Concentrate’s anti-catabolic, anti-inflammatory benefits to deliver a structured, evidence-based, synergistic therapy. This approach offers faster relief and significantly better long-term durability, positioning our practice as a center for premium, cutting-edge care.

The best protocol is part of a complete system—one that integrates advanced biologicals with expert diagnostics, chiropractic care, and targeted rehabilitation. By tracking our outcomes and continually improving this system, we can give our patients the confidence and results they deserve.

References

• Schineanu, M., Schineanu, S., Bratu, D., & Ilie, D. (2016). Colloid protein fluid concentrate in patients with moderate-to-severe knee osteoarthritis. Journal of Medicine and Life, 9(3), 287–292. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152605/

SEO Tags: Protein Concentrate, PRP Therapy, Integrative Chiropractic Care, Alpha-2-Macroglobulin, A2M, Knee Osteoarthritis, Regenerative Medicine, Dr. Alex Jimenez, Functional Medicine, Sports Medicine, Chronic Tendinopathy, Adhesive Capsulitis, Musculoskeletal Health, Evidence-Based Treatment, Joint Pain Relief, Anti-inflammatory Therapy, Catabolic Inhibitors